Results for this period
Interim period (second quarter)1 March 2026 to 31 August 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Measures including product policies, systems and DX, and store development to generate integration synergies and build a foundation for value creation following the business integration with Welcia Holdings. The disclosure also states that the company captured demand in the dispensing pharmacy business, expanded the food category, opened 53 new stores, and closed 77 stores.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 March 2026 to 31 August 2026 |
| Net Sales | 1,275,514 Millions of yen (YoY +128.7%) |
| Operating profit | 54,770 Millions of yen (YoY +92.6%) |
| Ordinary income | 54,850 Millions of yen (YoY +90.3%) |
| Profit attributable to owners of the parent | 30,252 Millions of yen (YoY +48.5%) |
| Net income per share | ¥66.75 |
| Equity ratio | End of the current fiscal period 56.4% / End of previous period 53.1% |
| Total assets | 1,588,272 Millions of yen |
| Net assets | 917,791 Millions of yen |
| Cash flows from operating activities | -17,015 Millions of yen |
| Cash flows from investing activities | -19,901 Millions of yen |
| Cash flows from financing activities | -23,869 Millions of yen |
| Cash and cash equivalents at end of period | 140,694 Millions of yen |
| Full-year earnings forecast | Net Sales 2,555,000 Millions of yen (YoY +76.1%) / Operating profit 99,400 Millions of yen (YoY +57.7%) / Ordinary income 98,100 Millions of yen (YoY +55.5%) / Net income 41,500 Millions of yen (YoY -2.7%) |
| Revision to Earnings Forecast | No (unchanged) |
| Annual Dividend Forecast | 248.50 (excluding the stock split) → ¥48 |
| Depreciation and amortization | 18,972 Millions of yen |
| Impairment loss | ¥554 million (target assets not specified) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets 180 Millions of yen, Gain on sale of investment securities 1,161 Millions of yen, Reversal of provision for store closure losses 465 Millions of yen, Other 223 Millions of yen / Extraordinary loss Loss on Disposal of Fixed Assets 69 Millions of yen, Loss on sale of fixed assets 17 Millions of yen, Impairment Losses 554 Millions of yen, Provision for store closure losses 1,172 Millions of yen, Other 81 Millions of yen |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes (number and names of companies newly consolidated or excluded: Not disclosed) |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 454,659,990 shares |
| Treasury Shares at Period-End | 983,568 treasury shares |
| Factors Behind Changes in Business Performance | Measures including product policies, systems and DX, and store development to generate integration synergies and build a foundation for value creation following the business integration with Welcia Holdings. The disclosure also states that the company captured demand in the dispensing pharmacy business, expanded the food category, opened 53 new stores, and closed 77 stores. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Following the business integration with Welcia Holdings, the company pursued measures including product policies, systems and DX, and store development to generate integration synergies and build a foundation for value creation. It also explained that progress had been made in capturing demand in the dispensing pharmacy business and expanding the food category.